EU Firms Invited To Discuss Advance COVID-19 Vaccine Contracts

Commission Says Strategy ‘Will Avoid Competition Between Us’

A common EU approach to the purchasing of COVID-19 vaccines has been welcomed by national health ministers. The strategy involves advance payments to companies to help build up manufacturing capacity and reserve quantities of vaccines once they become available.  

Injection
The EU wants companies to negotiate purchase deals for COVID-19 vaccines • Source: Shutterstock

The European Commission is planning to issue an invitation to manufacturers in the EU to enter into negotiations on advance purchase agreements for future COVID-19 vaccines, as part of a strategy aimed at ensuring any vaccines that are approved are made available quickly across Europe.

The commission’s proposal is to negotiate advance contracts and reservations of vaccine dosages with companies on behalf of the EU...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography